Alcoholism is a complex disease caused by a confluence of environmental and genetic factors influencing multiple brain pathways to produce a variety of behavioral sequelae, including addiction. Genetic factors contribute to over 50% of the risk for alcoholism and recent evidence points to a large number of genes with small effect sizes as the likely molecular basis for this disease. Recent progress in genomics (microarrays or RNA-Seq) and genetics has led to the identification of a large number of potential candidate genes influencing ethanol behaviors or alcoholism itself. To organize this complex information, investigators have begun to focus on the contribution of gene networks, rather than individual genes, for various ethanol-induced behaviors in animal models or behavioral endophenotypes comprising alcoholism. This chapter reviews some of the methods used for constructing gene networks from genomic data and some of the recent progress made in applying such approaches to the study of the neurobiology of ethanol. We show that rapid technology development in gathering genomic data, together with sophisticated experimental design and a growing collection of analysis tools are producing novel insights for understanding the molecular basis of alcoholism and that such approaches promise new opportunities for therapeutic development.
Introduction
Alcoholism is a prevalent and serious behavioral disease characterized by progression from intermittent social use of ethanol to abusive and uncontrolled consumption. As with other drug abuse disorders, the underlying neurobiological etiology of alcohol abuse and alcoholism is thought to involve long-lasting aberrant molecular plasticity in the central nervous system. Although multiple biological and environmental factors may converge en route to the manifestation and sustainability of this disease, altered function or expression of genes and gene networks are considered major factors contributing to long-lasting CNS changes causing the behavioral phenotype of alcoholism. The advent of high-throughput, unbiased approaches to studying genomic structure and expression, such as proteomics, DNA microarrays, whole genome SNP analysis and Next-Gen sequencing technologies, are providing new insights into gene sets involved in complex diseases. However, long lists of genes do not in themselves provide improved understanding of diseases such as alcoholism. New experimental approaches, combined with advanced statistical and bioinformatics support, have recently allowed organization of results from whole-genome studies into novel functional networks of genes related to the trait under study. Rather than focusing on an individual gene, the investigator can now simultaneously probe the entire genome to assess the interaction among individual genes. Provided 
